10 reports of this reaction
1.5% of all BENZOCAINE AND MENTHOL reports
#16 most reported adverse reaction
DEEP VEIN THROMBOSIS is the #16 most commonly reported adverse reaction for BENZOCAINE AND MENTHOL, manufactured by RB Health (US) LLC. There are 10 FDA adverse event reports linking BENZOCAINE AND MENTHOL to DEEP VEIN THROMBOSIS. This represents approximately 1.5% of all 672 adverse event reports for this drug.
Patients taking BENZOCAINE AND MENTHOL who experience deep vein thrombosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEEP VEIN THROMBOSIS is a less commonly reported adverse event for BENZOCAINE AND MENTHOL, but still significant enough to appear in the safety profile.
In addition to deep vein thrombosis, the following adverse reactions have been reported for BENZOCAINE AND MENTHOL:
The following drugs have also been linked to deep vein thrombosis in FDA adverse event reports:
DEEP VEIN THROMBOSIS has been reported as an adverse event in 10 FDA reports for BENZOCAINE AND MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEEP VEIN THROMBOSIS accounts for approximately 1.5% of all adverse event reports for BENZOCAINE AND MENTHOL, making it a notable side effect.
If you experience deep vein thrombosis while taking BENZOCAINE AND MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.